SCHEMBL4228952

SCHEMBL4228952

O=C(O)NCCc1nc(C2CC2)no1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.45
AKR1C3 P42330 1/20 0.45
AKR1C2 P52895 1/20 0.45
AKR1C1 Q04828 1/20 0.45
LDHA P00338 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
HSD11B1 P28845 1/20 0.41
GABRA5 P31644 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
FABP4 P15090 5/20 0.36
FABP5 Q01469 5/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CNR2 P34972 1/20 0.35
GAA P10253 1/20 0.34
CCR5 P51681 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30639580 0.85 CYP1A2 (0.42) AKR1C4AKR1C3AKR1C2AKR1C1LDHA
SCHEMBL13853476 0.84 HSD11B1 (0.41) AKR1C4AKR1C3AKR1C2AKR1C1LDHA
SCHEMBL3954081 0.80 HTT (0.48) HSD11B1MEN1KMT2AGAA
SCHEMBL13731980 0.76 CYP2C9 (0.39) KMT2ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL30639536 0.75 HSD11B1 (0.42) AKR1C4AKR1C3AKR1C2AKR1C1LDHA
Hydrochloric Acid SCHEMBL30639619 0.74 HSD11B1 (0.41) AKR1C4AKR1C3AKR1C2AKR1C1LDHA
SCHEMBL4224253 0.72 KDM4E (0.38) L3MBTL1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL26226450 0.72 L3MBTL1 (0.44) AKR1C4AKR1C3AKR1C2AKR1C1LDHA
SCHEMBL1786515 0.72 L3MBTL1 (0.44) AKR1C4AKR1C3AKR1C2AKR1C1LDHA
SCHEMBL24258804 0.72 AKR1C4 (0.44) AKR1C4AKR1C3AKR1C2AKR1C1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354418-B2 Thiazolyl-dihydro-quinazolines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-15 US disclosed
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-21 US disclosed
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE ROR1, RORB, RORA AKR1C4 120/4885AKR1C3 163/4885AKR1C2 186/4885
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE CYP3A7, UGT2B7, UGT1A7 AKR1C4 484/4885AKR1C3 706/4885AKR1C2 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.